Article Figures & Data
Tables
Total (n = 224) Ruptured BAVMs (n = 136) Unruptured BAVMs (n = 88) P Value Age (yr) 37.8 ± 16 37.9 ± 17.7 37.6 ± 13.3 .087 Male 127 (57%) 81 (60%) 46 (52%) .282 Presentation NA Hemorrhage 136 (60%) 136 (100%) 0 (0%) Seizure 42 (19%) 0 (0%) 42 (48%) Incidental 37 (17%) 0 (0%) 37 (42%) Other 9 (4%) 0 (0%) 9 (10%) Initial mRS score .0001 Good (0–2) 178 (79%) 91 (67%) 87 (99%) Poor (3–5) 46 (21%) 45 (33%) 1 (1%) BAVM location .001 Cortical and subcortical 176 (79%) 96 (71%) 80 (90%) Deep 19 (8%) 15 (11%) 4 (5%) Infratentorial 29 (13%) 25 (18%) 4 (5%) Eloquent area 77 (34%) 55 (40%) 22 (25%) .017 Spetzler-Martin grade .361 I 71 (32%) 40 (29%) 31 (35%) II 153 (68%) 96 (71%) 57 (65%) Mean nidus diameter (cm) 2.1 ± 1.1 1.9 ± 1.1 2.4 ± 1.1 .0001 Deep venous drainage 45 (20%) 32 (24%) 13 (15%) .126 Venous ectasia 54 (24%) 27 (20%) 27 (31%) .061 Arterial aneurysm 20 (9%) 14 (10%) 6 (7%) .475 Intranidal aneurysm 42 (19%) 33 (24%) 9 (10%) .020 Mean No. of procedures 1.6 ± 0.9 1.4 ± 0.8 1.8 ± 1.1 .003 Duration of follow-up angiography (mo) 9.7 ± 11.9 8.7 ± 10.4 11.3 ± 13.8 .117 Angiographic result .091 Complete exclusion 205 (92%) 128 (94%) 77 (88%) Remnant 19 (8%) 8 (6%) 11 (12%) 1.000 Post-EVT AVM surgery 7 (3%) 4 (3%) 3 (4%) NA Post-EVT radiosurgery 8 (4%) 2 (2%) 6 (8%) NA Severe post-EVT hematoma 11 (5%) 7 (5%) 4 (5%) 1.000 Significant post-EVT ischemia 5 (2%) 4 (3%) 1 (1%) .651 Postop outcome (mRS) .001 Good (0–2) 179 (80%) 96 (71%) 83 (94%) Poor (3–5) 44 (19%) 40 (29%) 4 (5%) Mortality (6) 1 (0.4%) 0 (0%) 1 (1%) Improved/unchanged mRS score 211 (94%) 127 (93%) 85 (96%) 1.000 Note:—NA indicates not applicable; postop, postoperative.
↵a Data are presented as No. (%) or means.
Total Complete Exclusion Remnant P Valueb Location .338 Cortical and subcortical 176 (100%) 159 (90.3%) 17 (9.7%) Deep 19 (100%) 19 (100%) 0 (0%) Infratentorial 29 (100%) 27 (93.1%) 2 (6.9%) Eloquent 77 (100%) 76 (98.7%) 1 (1.3%) .004 Noneloquent 147 (100%) 129 (87.8%) 18 (12.2%) - Table 3:
Summary of endovascular treatment for low-grade brain arteriovenous malformationsa
Author, Year No. of Patients Morbidity Mortality Cure Rate Maimon et al, 201010 8 0 (0%) 0 (0%) 5 (63%) van Rooji WJ et al, 20127 20 0 (0%) 0 (0%) 19 (96%) Xu et al, 201119 16 1 (6.3%) 0 (0%) 9 (56%) Saatci et al, 201118 158 4 (2.5%) 1 (0.6%) 155 (98%) Abud et al, 201112 8 1 (12.5%) 0 (0%) 8 (100%) Durst et al, 201520 5 NA 0 (0%) 5 (100%) Our study, 2018 224 12 (5.4%) 1 (0.4%) 206 (92%) Total 439 18 (4.1%) 2 (0.5%) 407 (93%) Note:—NA indicates not applicable.
↵a Data are presented as No. (%).